Literature DB >> 11431238

Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study.

P Alonso1, J Pujol, N Cardoner, L Benlloch, J Deus, J M Menchón, A Capdevila, J Vallejo.   

Abstract

OBJECTIVE: The efficacy of repetitive transcranial magnetic stimulation (rTMS) of the right prefrontal cortex for patients with obsessive-compulsive disorder (OCD) was studied under double-blind, placebo-controlled conditions.
METHOD: Patients were randomly assigned to 18 sessions of real (N=10) or sham (N=8) rTMS. Treatments lasted 20 minutes, and the frequency was 1 Hz for both conditions, but the intensity was 110% of motor threshold for real rTMS and 20% for the sham condition.
RESULTS: No significant changes in OCD were detected in either group after treatment. Two patients who received real rTMS, with checking compulsions, and one receiving sham treatment, with sexual/religious obsessions, were considered responders.
CONCLUSIONS: Low-frequency rTMS of the right prefrontal cortex failed to produce significant improvement of OCD and was not significantly different from sham treatment. Further studies are indicated to assess the efficacy of rTMS in OCD and to clarify the optimal stimulation characteristics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431238     DOI: 10.1176/appi.ajp.158.7.1143

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  36 in total

1.  Algorithm for the pharmacotherapy of anxiety disorders.

Authors:  Dan J Stein
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

2.  Is there evidence for effectiveness of transcranial magnetic stimulation in the treatment of psychiatric disorders?

Authors:  Biju Basil; Jamal Mahmud; Maju Mathews; Carlos Rodriguez; Babatunde Adetunji
Journal:  Psychiatry (Edgmont)       Date:  2005-11

3.  Neuromodulation and Transcranial Mag Netic Stimulation (TMS): A 21st Century Paradigm for Therapeutics in Psychiatry.

Authors:  John P O'Reardon; Andrew D Peshek; Rocio Romero; Pilar Cristancho
Journal:  Psychiatry (Edgmont)       Date:  2006-01

4.  Repetitive transcranial magnetic stimulation (rTMS) augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant obsessive-compulsive disorder (OCD): a meta-analysis of randomized controlled trials.

Authors:  Zhong-Rui Ma; Li-Jun Shi
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 5.  Neuromodulation for obsessive-compulsive disorder.

Authors:  Kyle A B Lapidus; Emily R Stern; Heather A Berlin; Wayne K Goodman
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 6.  Transcranial cortical stimulation in the treatment of obsessive-compulsive disorders: efficacy studies.

Authors:  Ghassen Saba; Albert Moukheiber; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2015-05       Impact factor: 5.285

Review 7.  A Meta-Analysis of the Effectiveness of Different Cortical Targets Used in Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Obsessive-Compulsive Disorder (OCD).

Authors:  Simone Rehn; Guy D Eslick; Vlasios Brakoulias
Journal:  Psychiatr Q       Date:  2018-09

Review 8.  Review of structural neuroimaging in patients with refractory obsessive-compulsive disorder.

Authors:  Murad Atmaca
Journal:  Neurosci Bull       Date:  2011-06       Impact factor: 5.203

9.  Augmentation effect of repetitive transcranial magnetic stimulation over the orbitofrontal cortex in drug-resistant obsessive-compulsive disorder patients: a controlled investigation.

Authors:  Chiara Ruffini; Marco Locatelli; Adelio Lucca; Francesco Benedetti; Chiara Insacco; Enrico Smeraldi
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 10.  Transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder.

Authors:  J L R Martin; M J Barbanoj; V Pérez; M Sacristán
Journal:  Cochrane Database Syst Rev       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.